Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis
Authors
Keywords
-
Journal
Acta Pharmaceutica Sinica B
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-12-30
DOI
10.1016/j.apsb.2021.12.016
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proliferation tracing reveals regional hepatocyte generation in liver homeostasis and repair
- (2021) Lingjuan He et al. SCIENCE
- T Lymphocyte-Mediated Liver Immunopathology of Schistosomiasis
- (2020) Bing Zheng et al. Frontiers in Immunology
- Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics
- (2020) Qingke Li et al. CELL
- Differential GLP-1R Binding and Activation by Peptide and Non-peptide Agonists
- (2020) Xin Zhang et al. MOLECULAR CELL
- Endothelin receptors promote schistosomiasis-induced hepatic fibrosis via splenic B cells
- (2020) Hongyan Kong et al. PLoS Pathogens
- AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis
- (2020) Hongjiao Xu et al. Nature Communications
- Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation
- (2019) Brittany L. Baechler et al. Autophagy
- Praziquantel Ameliorates CCl 4 ‐induced Liver Fibrosis in Mice by Inhibiting TGF‐β/Smad Signalling via Upregulating Smad7 in Hepatic Stellate Cells
- (2019) Jinfeng Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dual glucagon‐like peptide‐1 receptor/glucagon receptor agonist SAR425899 improves beta‐cell function in type 2 diabetes
- (2019) Roberto Visentin et al. DIABETES OBESITY & METABOLISM
- Genetically Encoding Fluorosulfate-l-tyrosine To React with Lysine, Histidine, and Tyrosine via SuFEx in Proteins in Vivo
- (2018) Nanxi Wang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
- (2018) Philip Ambery et al. LANCET
- Liver fibrosis: Direct antifibrotic agents and targeted therapies
- (2018) Detlef Schuppan et al. MATRIX BIOLOGY
- Exendin‐4 from Heloderma suspectum venom: From discovery to its latest application as type II diabetes combatant
- (2018) Michelle Khai Khun Yap et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Rapeseed Protein-Derived Antioxidant Peptide RAP Ameliorates Nonalcoholic Steatohepatitis and Related Metabolic Disorders in Mice
- (2018) Qian Zhao et al. MOLECULAR PHARMACEUTICS
- Host Regulators of Liver Fibrosis During Human Schistosomiasis
- (2018) Severin Donald Kamdem et al. Frontiers in Immunology
- A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice
- (2017) M. Pilar Valdecantos et al. HEPATOLOGY
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- The liver-enriched lnc-LFAR1 promotes liver fibrosis by activating TGFβ and Notch pathways
- (2017) Kun Zhang et al. Nature Communications
- Liraglutide improves liver microvascular dysfunction in cirrhosis: Evidence from translational studies
- (2017) Fernanda Cristina de Mesquita et al. Scientific Reports
- Dose-dependent effects of alpha-naphthylisothiocyanate disconnect biliary fibrosis from hepatocellular necrosis
- (2016) Nikita Joshi et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Hepcidin inhibits Smad3 phosphorylation in hepatic stellate cells by impeding ferroportin-mediated regulation of Akt
- (2016) Chang Yeob Han et al. Nature Communications
- Experimental models of liver fibrosis
- (2015) Sara Crespo Yanguas et al. ARCHIVES OF TOXICOLOGY
- Schistosome-induced cholangiocyte proliferation and osteopontin secretion correlate with fibrosis and portal hypertension in human and murine schistosomiasis mansoni
- (2015) T. A. Pereira et al. CLINICAL SCIENCE
- Hepatic inflammation and fibrosis: Functional links and key pathways
- (2015) Ekihiro Seki et al. HEPATOLOGY
- The Hippo pathway effector YAP controls mouse hepatic stellate cell activation
- (2015) Inge Mannaerts et al. JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
- (2013) H. Kahal et al. CLINICAL ENDOCRINOLOGY
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches
- (2012) Ekihiro Seki et al. GASTROENTEROLOGY
- Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
- (2012) Juliane S. Troeger et al. GASTROENTEROLOGY
- Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
- (2012) T. Kisseleva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Pathogenesis of Liver Fibrosis
- (2011) Virginia Hernandez-Gea et al. Annual Review of Pathology-Mechanisms of Disease
- Partial bile duct ligation in mice: A novel model of acute cholestasis
- (2010) Stefan Heinrich et al. SURGERY
- Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
- (2009) A. Pocai et al. DIABETES
- Experimental mouse models for hepatocellular carcinoma research
- (2009) Femke Heindryckx et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
- (2009) Jonathan W Day et al. Nature Chemical Biology
- Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular Domain
- (2008) Steffen Runge et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now